Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 46

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 46
---
itech Vascular business (1996 to 1999). He is the Co-Chair of our Global Council for Inclusion and currently is a director of Waters Corporation (since 2022), a publicly-traded analytical laboratory instrument and software company, and a former board member of Nuance Communications and Overseers of Babson College (2018-2022). Mr. Brennan received an MBA and BS degree in finance and investments from Babson College and is also a certified public accountant. |

| Vance R. Brown                                            
 Senior Vice President,General Counsel,Corporate Secretary |     | Mr. Brown, age 55, is our Senior Vice President, General Counsel and Corporate Secretary, a position he has held since June 2021. In this role, he provides global legal leadership across all of our businesses, regions and functions and oversees the Company’s global compliance function. Since joining the Company in 2001, Mr. Brown has served in a variety of legal and compliance roles of increasing responsibility, including VP, Chief Corporate Counsel and Assistant Secretary from 2010 to 2021, leading and overseeing our international legal teams and various corporate legal functions, including mergers and acquisitions, venture capital, corporate governance and securities. Mr. Brown is a member of our Global Council for Inclusion. Before joining the Company, he was an attorney with Skadden, Arps, Slate, Meagher and Flom. He received a JD from Harvard Law School and a BA from University of Western Ontario. |

| Arthur C. Butcher                                                    
 Executive Vice Presidentand Group President,MedSurg and Asia Pacific |     | Mr. Butcher, age 54, is our Executive Vice President and Group President, MedSurg and Asia Pacific, a position he has held sinceMay 2022.In this role, he oversees Asia Pacific, as well as our Urology, Endoscopy and Neuromodulation businesses. Since joining the Company in 1997, Mr. Butcher has held management roles of increasing responsibility and has deep experience across the Company’s divisions, including Executive Vice President and President, Asia Pacific (2020 to 2022), responsible for commercialization of our full product portfolio across all divisions in the Asia Pacific region; Senior Vice President and President, Endoscopy (2016 to 2020), responsible for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions; VP & General Manager, Japan Endoscopy (2014 to 2016); VP of Global Marketing, Endoscopy